the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)
Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
1. Gefitinib CTTQ production gefitinib and erlotinib sheet AstraZeneca imatinib sheet
(trade name: Iressa ®) comparison, human pharmacokinetics and relative bioavailability
of comparative studies which examine people in vivo pharmacokinetic behavior, provide
the basis for clinical use.
2. Evaluation CTTQ gefitinib imatinib sheet production efficacy and safety of Chinese
patients with locally advanced or metastatic non-small cell lung cancer.